Two important orders of the Ministry of Health of Ukraine were published in the Official Bulletin of Ukraine on the introduction of a reference pricing for medicinal products, which approved:
Thus, the List includes 23 INNs (international nonproprietary names) of medicinal products that were selected on the basis of the following criteria:
The orders of the Ministry of Health of Ukraine dated July 11, 2019 No.1600 and July 29, 2019 No.1713 entered into force on the day of their official publication.
It should be reminded that these instruments were introduced to implement the CMU Resolution of April 3rd, 2019 No. 426 “On Reference Pricing for Some Medicinal Products Procured for Budget Funds,” which provides for the introduction of a reference pricing for some medicines from the National List.
In accordance with the provisions of the aforementioned resolution, the Ministry of Health of Ukraine also approves the Register of Maximum Wholesale Prices for Medicinal Products Included in the List, the approval of which is expected in the near future.
As soon as such a Register enters into force, health care institutions fully or partially financed from the state and local budgets will be able to procure medicines from the List at prices that do not exceed maximum wholesale prices established by the MHU including taxes and duties, as well as maximum supply and sales (retail) margins determined by CMU Resolution No. 955 of October 17th, 2008 “On Measures to Stabilize Medicinal Products Prices”.
Thus, the new regulation will only deal with cases of procurement of medicines for budgetary funds. If such medicines are sold only through pharmacies to end consumers, the established price restrictions will not apply.
Contact the author: Natalia Spivak, Senior Associate, Legal Alliance Company, spivak@l-a.com.ua.
We are thrilled to announce a major milestone in our team's growth and celebrate the well-deserved career advancements of our colleagues.
Lexology Index: Employment & Labor highlights the leading legal specialists in the field from around the world.
On June 19, 2026, an event was held with the participation of businesses, regulators, and experts – titled “Regulatory Dialogue: The Cosmetics Market” – organiz
The event brought together leading industry experts for a comprehensive analysis of the institutional landscape and current legal challenges in the sphere of state-business interaction.